NEW YORK--(BUSINESS WIRE)--Oliver Wyman, a global leader in management consulting and a business of Marsh McLennan (NYSE: MMC), today announced an agreement to acquire Validate Health, a healthcare analytics business that enables healthcare providers and Accountable Care Organizations (ACOs) to better manage costs, risk, and performance. The terms of the transaction, expected to close in summer 2025, were not disclosed. Validate Health will join Oliver Wyman Actuarial, a specialized business wi.
MMC's roll-up strategy, highlighted by the McGriff acquisition, has driven impressive scale, recurring revenue, and margin expansion in the insurance brokerage sector. Consistently high returns on equity and invested capital, well above peers, demonstrate MMC's durable competitive advantages and management's capital allocation skill. Valuation remains reasonable relative to historical ranges, despite significant improvements in margins and returns, making MMC attractive for long-term investors.
MMC has maintained consistent cash flow generation for several years, supporting its disciplined capital distribution.
![]() MSN 2 months ago | Other | €0.71 Per Share |
![]() MSN 4 months ago | Other | €0.71 Per Share |
![]() MSN 8 months ago | Other | €0.71 Per Share |
![]() MSN 11 months ago | Other | €0.71 Per Share |
![]() MSN 3 Apr 2024 | Other | €0.62 Per Share |
16 Jul 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
16 Apr 2025 Date | | - Cons. EPS | - EPS |
23 Jan 2025 Date | | - Cons. EPS | - EPS |
17 Oct 2024 Date | | - Cons. EPS | - EPS |
18 Jul 2024 Date | | - Cons. EPS | - EPS |
![]() MSN 2 months ago | Other | €0.71 Per Share |
![]() MSN 4 months ago | Other | €0.71 Per Share |
![]() MSN 8 months ago | Other | €0.71 Per Share |
![]() MSN 11 months ago | Other | €0.71 Per Share |
![]() MSN 3 Apr 2024 | Other | €0.62 Per Share |
16 Jul 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
16 Apr 2025 Date | | - Cons. EPS | - EPS |
23 Jan 2025 Date | | - Cons. EPS | - EPS |
17 Oct 2024 Date | | - Cons. EPS | - EPS |
18 Jul 2024 Date | | - Cons. EPS | - EPS |
Insurance - Brokers Industry | Financial Services Sector | Mr. John Quinlan Doyle CEO | XMUN Exchange | US5717481023 ISIN |
US Country | 90,000 Employees | 3 Apr 2025 Last Dividend | 1 Jul 2002 Last Split | 30 Dec 1987 IPO Date |
Marsh & McLennan Companies, Inc. is a globally recognized professional services firm that specializes in offering comprehensive advice and tailored solutions in the realms of risk, strategy, and people. The company has established a prestigious reputation since its inception in 1871, with its headquarters situated in the bustling city of New York, New York. Marsh & McLennan operates through two main segments: Risk and Insurance Services, and Consulting, catering to a wide array of clients including businesses, public entities, insurance companies, associations, professional services organizations, and private clients across the world.
This suite of services encompasses expert advice on risk identification and assessment, risk transfer, and risk control and mitigation solutions. Marsh & McLennan provides clients with insurance and reinsurance broking, strategic advisory services, analytics solutions, and insurance program management, aimed at effectively managing and minimizing risk.
The Consulting segment of Marsh & McLennan delivers specialized services across three primary areas: Health, Wealth, and Career. Health consulting offers solutions that help clients manage healthcare costs and improve the health and well-being of their workforce. Wealth consulting involves advice and solutions related to retirement, compensation, and investment planning to secure financial future and manage wealth. Career consulting provides insights and strategies for talent management, organizational effectiveness, and workforce strategies. Additionally, the company provides specialized management, strategic, economic, and brand consulting services to further support the organizational goals of its clients.